Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniela Espíndola-Antunes"'
Autor:
Paulo Gentil, Lucas Raphael Bento e Silva, Daniela Espíndola Antunes, Luciana Barbosa Carneiro, Claudio Andre Barbosa de Lira, Gislene Batista, Jordana Campos Martins de Oliveira, John Sebastião Cardoso, Daniel CostaCosta Souza, Ana Cristina Silva Rebelo
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
ObjectiveTo compare the effects of different aerobic training protocols on cardiometabolic variables in patients with type 2 diabetes mellitus (T2DM).MethodsThis study was a parallel clinical trial. Fifty-two men and women with T2DM (>40 years) were
Externí odkaz:
https://doaj.org/article/c509177b756e40b4beb7d6349616b5d2
Autor:
Cecília Pacheco Elias, Daniela Espíndola Antunes, Michella Soares Coelho, Caroline Lourenço de Lima, Nelson Rassi, Ana Paula Meireles de Melo, Angélica Amorim Amato
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-8 (2019)
Abstract Background Familial partial lipodystrophy (FPL) is a rare genetic disease characterized by body fat abnormalities that lead to insulin resistance (IR). Clinical conditions linked to milder IR, such as type 2 diabetes (T2D) and metabolic synd
Externí odkaz:
https://doaj.org/article/460246f0a87c48e4985dd438aec645ab
Autor:
Monike Lourenço Dias, Allyne Fernanda de Paula, Maria Aparecida Lopes Reis, Paula Novais Rabelo, Daniela Pultrini Pereira de Oliveira Viggiano, Estela Muszkat Jatene, Samuel Amanso da Conceição, Daniela Espíndola Antunes, Patrícia Novais Rabelo, Sílvia Leda França Moura de Paula
Publikováno v:
Revista da Associação Médica Brasileira, Vol 65, Iss 6, Pp 755-760
Revista da Associação Médica Brasileira v.65 n.6 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira v.65 n.6 2019
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
SUMMARY INTRODUCTION: Graves’ disease (GD) is an autoimmune disorder characterized by hyperthyroidism. Antithyroid drugs (ATDs) are available as therapy. Agranulocytosis is a rare but potentially fatal complication of this therapy. In this study, w
Autor:
Angélica Amorim Amato, Michella Soares Coelho, Caroline Lourenço de Lima, Nelson Rassi, Daniela Espíndola Antunes, Cecília Pacheco Elias, Ana Paula de Melo
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-8 (2019)
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome
Background Familial partial lipodystrophy (FPL) is a rare genetic disease characterized by body fat abnormalities that lead to insulin resistance (IR). Clinical conditions linked to milder IR, such as type 2 diabetes (T2D) and metabolic syndrome, are
Autor:
Soraya Lopes Sader, Fernanda Guimarães Weiler, Marise Lazaretti-Castro, Joya E. M. Correia-Deur, Daniela Espíndola-Antunes, Magnus R. Dias-da-Silva, Beatriz Tavares Costa-Carvalho, Pärt Peterson, Gil Guerra-Júnior, Mayra de Barros Dorna
Publikováno v:
Clinical Immunology. 197:231-238
Autoimmune polyendocrine syndrome type 1 (APS1) is characterized by multiorgan autoimmunity. We aim at characterizing a multi-center Brazilian cohort of APS1 patients by clinical evaluation, searching mutation in the AIRE gene, measuring serum autoan
Publikováno v:
Arquivos brasileiros de endocrinologia e metabologia. 51(8)
Glucocorticoids have a major role in determining adipose tissue metabolism and distribution. 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) is a NADPH-dependent enzyme highly expressed in the liver and adipose tissue. In most intact cells an